Open AccessCytolytic syndrome associated with the treatment for COVID-19
Author(s) -
Д. Е. Данилов
Publication year - 2021
Publication title -
problemy zdorovʹâ i èkologii
Language(s) - English
Resource type - Journals
eISSN - 2708-6011
pISSN - 2220-0967
DOI - 10.51523/2708-6011.2021-18-2-20
Subject(s) - cytolysis , steatosis , covid-19 , medicine , virology , disease , elevated transaminases , coronavirus , immunology , gastroenterology , biology , infectious disease (medical specialty) , cytotoxic t cell , outbreak , in vitro , biochemistry
The article describes a clinical case of an increased level of hepatic transaminases during a delayed period of the treatment in a patient with coronavirus disease COVID-19 using remdesivir and a possible effect of hepatic steatosis on the severity of cytolytic syndrome associated with the course of COVID-19.